comparemela.com

Latest Breaking News On - Prothena co - Page 5 : comparemela.com

Silverarc Capital Management LLC Has $1 29 Million Holdings in Prothena Co plc (NASDAQ:PRTA)

Silverarc Capital Management LLC decreased its stake in shares of Prothena Co. plc (NASDAQ:PRTA – Free Report) by 46.4% in the 3rd quarter, Holdings Channel reports. The fund owned 26,629 shares of the biotechnology company’s stock after selling 23,092 shares during the quarter. Silverarc Capital Management LLC’s holdings in Prothena were worth $1,285,000 as of […]

Prothena Co plc (NASDAQ:PRTA) Sees Significant Decrease in Short Interest

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 31st, there was short interest totalling 5,750,000 shares, a decrease of 8.1% from the January 15th total of 6,260,000 shares. Based on an average daily trading volume, of 845,900 […]

Prothena Co plc (NASDAQ:PRTA) Sees Large Decline in Short Interest

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) was the recipient of a large decline in short interest in January. As of January 31st, there was short interest totalling 5,750,000 shares, a decline of 8.1% from the January 15th total of 6,260,000 shares. Based on an average trading volume of 845,900 shares, the short-interest ratio […]

Prothena Co plc (NASDAQ:PRTA) Sees Large Decline in Short Interest

Prothena Co. plc (NASDAQ:PRTA – Get Free Report) saw a large decrease in short interest in the month of January. As of January 31st, there was short interest totalling 5,750,000 shares, a decrease of 8.1% from the January 15th total of 6,260,000 shares. Based on an average daily trading volume, of 845,900 shares, the short-interest […]

1,531 Shares in Prothena Co plc (NASDAQ:PRTA) Acquired by Headlands Technologies LLC

Headlands Technologies LLC bought a new position in Prothena Co. plc (NASDAQ:PRTA – Free Report) during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 1,531 shares of the biotechnology company’s stock, valued at approximately $74,000. Other large investors have also made changes to their positions […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.